Medtronic plc Files 8-K on Financial Condition

Ticker: MDT · Form: 8-K · Filed: 2025-02-18T00:00:00.000Z

Sentiment: neutral

Topics: debt, financial-condition, sec-filing

TL;DR

Medtronic dropped an 8-K on Feb 18, 2025, detailing its various senior notes and their interest rates. All good.

AI Summary

On February 18, 2025, Medtronic plc filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior notes due in 2025, 2027, 2028, 2029, and 2031, with interest rates ranging from 0.000% to 3.650%. This filing is a standard disclosure for the company's ongoing financial reporting.

Why It Matters

This filing provides investors with updated information on Medtronic's financial structure, specifically concerning its outstanding debt obligations, which is crucial for assessing the company's financial health and investment risk.

Risk Assessment

Risk Level: low — This is a routine financial disclosure filing and does not appear to contain any new or significant negative information.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by Medtronic plc?

The purpose of this 8-K filing is to report on Medtronic plc's Results of Operations and Financial Condition, including details on various senior notes.

What are the maturity dates for the senior notes mentioned in the filing?

The filing mentions senior notes due in 2025, 2027, 2028, 2029, and 2031.

What is the range of interest rates for the mentioned senior notes?

The interest rates for the senior notes range from 0.000% to 3.650%.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted on February 18, 2025.

Does the filing indicate any new financial events or material changes for Medtronic plc?

The filing primarily details existing financial instruments (senior notes) and their terms, suggesting it's a routine disclosure rather than an announcement of a new material event.

From the Filing

0001613103-25-000019.txt : 20250218 0001613103-25-000019.hdr.sgml : 20250218 20250218064640 ACCESSION NUMBER: 0001613103-25-000019 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250218 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250218 DATE AS OF CHANGE: 20250218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0425 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 25632671 BUSINESS ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20250218.htm 8-K mdt-20250218 0001613103 H91 VY19 false 0001613103 2025-02-18 2025-02-18 0001613103 us-gaap:CommonStockMember 2025-02-18 2025-02-18 0001613103 mdt:A0.250SeniorNotesDue2025Member 2025-02-18 2025-02-18 0001613103 mdt:A0.000SeniorNotesDue2025Member 2025-02-18 2025-02-18 0001613103 mdt:A2.625SeniorNotesDue2025Member 2025-02-18 2025-02-18 0001613103 mdt:A1.125SeniorNotesDue2027Member 2025-02-18 2025-02-18 0001613103 mdt:A0.375SeniorNotesDue2028Member 2025-02-18 2025-02-18 0001613103 mdt:A3.000SeniorNotesDue2028Member 2025-02-18 2025-02-18 0001613103 mdt:A3.650SeniorNotesDue2029Member 2025-02-18 2025-02-18 0001613103 mdt:A1.625SeniorNotesDue2031Member 2025-02-18 2025-02-18 0001613103 mdt:A1.000SeniorNotesDue2031Member 2025-02-18 2025-02-18 0001613103 mdt:A3.125SeniorNotesDue2031Member 2025-02-18 2025-02-18 0001613103 mdt:A0.750SeniorNotesDue2032Member 2025-02-18 2025-02-18 0001613103 mdt:A3.375SeniorNotesDue2034Member 2025-02-18 2025-02-18 0001613103 mdt:A3.875SeniorNotesDue2036Member 2025-02-18 2025-02-18 0001613103 mdt:A2.250SeniorNotesDue2039Member 2025-02-18 2025-02-18 0001613103 mdt:A1.500SeniorNotesDue2039Member 2025-02-18 2025-02-18 0001613103 mdt:A1.375SeniorNotesDue2040Member 2025-02-18 2025-02-18 0001613103 mdt:A4.150SeniorNotesDue2043Member 2025-02-18 2025-02-18 0001613103 mdt:A1.750SeniorNotesDue2049Member 2025-02-18 2025-02-18 0001613103 mdt:A1.625SeniorNotesDue2050Member 2025-02-18 2025-02-18 0001613103 mdt:A4.150SeniorNotesDue2053Member 2025-02-18 2025-02-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2025   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) Building Two Parkmore Business Park West Galway , Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to

View on Read The Filing